| Followers | 76 |
| Posts | 3281 |
| Boards Moderated | 0 |
| Alias Born | 03/16/2014 |
Thursday, November 10, 2022 8:52:24 AM
See below , IMMU were pre Ph3, pre revenue and of course miles form approval.
In Q2 2020 they had a m/c of $2bn ( which is kind of where we'd be if we were not on the OTC exchange ) and IMMU were bought out for $21bn in Q3 by Gilead .
Ponder this , market size of the triple negative breast cancer that IMMU treats vs nGBM and rGBM
Recent NWBO News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
